Document Classification

Section Type: RESULTS

Text: After 6 (M6) and 12 months of therapy, the bone resorption markers were significantly reduced in Group B : OHPr-41. 64 % at M6 (p < 0. 001) and -37. 91 % at M12 (p < 0. 001) ; DPD-33. 4 % at M6 (p < 0. 001) and -33. 18 % (p < 0. 001) at M12 : NTX -57. 08 % (p < 0. 001) at M6 and -55. 95 % (p < 0. 001) at M12 ; OC-11. 62 % (p = 0. 05) at M6 and -12. 62 % at M12 (p = 0. 06) ; B-ALP -13. 95 % at M6 (p = 0. 04) and -0. 85 % at M12 (NS).